HOME >> MEDICINE >> NEWS
JRRD releases single-topic issue focused on vision rehabilitation

Migration and proliferation of retinal pigment epithelium on extracellular matrix ligands, pg. 713

Our goal is to develop a surgical treatment that will improve vision for patients with agerelated macular degeneration (AMD). AMD is the most common cause of blindness among people over age 55 in the United States (including veterans). In most AMD patients with severe visual loss, abnormal blood vessels grow under the central retina (the area that provides high resolution vision) and cause bleeding, scarring, and blindness. If surgical excision of the abnormal vessels can be combined with resurfacing of the dissection area by the patient's own retinal pigment epithelial cells (RPE), then vision might be restored postoperatively. We studied the ability of young versus old RPE cells to grow in cell culture on surfaces that contain proteins believed to foster RPE migration and proliferation. We found that old as well as young RPE cells can grow in cell culture on surfaces that contain appropriate extracellular matrix ligands. These results will guide us in developing techniques to provide sight-restoring treatment for patients with exudative AMD.

Status of the feline retina 5 years after subretinal implantation, pg. 723

The long-term biocompatibility and durability of retinal prosthetics are essential components of a viable clinical device. In this study, we report results obtained 5 years following implantation of normal adult cats with a subretinal microphotodiode array. All implants functioned throughout the study period. Small changes in retinal function and morphology were noted that could be attributed to surgical manipulation or the presence of a solid device in the subretinal space. No indications of rejection of the prosthesis existed. Clinical trials to determine whether visual improvements exist in patients implanted with subretinal devices of similar design are in progress, while animal studies address the mechanisms that m
'"/>

Contact: Dore Mobley
dore@vard.org
410-962-1800 x229
Journal of Rehabilitation Research
11-Jan-2007


Page: 1 2 3 4 5 6

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. JRRD releases single-topic issue on pain and pain management
3. American College of Physicians releases new patient education resources
4. The AGA Institute releases report on the future of gastroenterology
5. Osteoarthritis initiative releases first data
6. ESC releases updated Guidelines for the Management of Stable Angina Pectoris
7. The ESC releases guidance document on Cardiac Rhythm Management product performance
8. Heart Rhythm Society releases draft recommendations on pacemakers, ICDs on April 26
9. ACP releases annual report on The State of the Nations Health Care
10. USP releases national report
11. CIHR releases research results to inform the development of benchmarks for wait times

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: JRRD releases single topic issue focused vision rehabilitation

(Date:4/18/2014)... turns 160 years of neuroanatomy on its head. , ... essential for the fast transmission of impulses along the ... thought, according to a new work lead by Professor ... and the University,s Department of Stem Cell and Regenerative ... Department of Molecular and Cellular Biology. , "Myelin is ...
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/17/2014)... in benign prostate tissue was associated with high-grade, ... found even in those with low prostate-specific antigen ... Cancer Epidemiology, Biomarkers & Prevention , a ... , An analysis of prostate tissue biopsies collected ... the Prostate Cancer Prevention Trial (PCPT) found that ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2
(Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
Cached News: